https://publichealth.ouhsc.edu/about Parent Page: About id: 34447 Active Page: details id: 34448

Directory

Elizabeth (Betsy) Charron, PhD, MS, MPH
Health Promotion Sciences

Elizabeth (Betsy) Charron, Ph.D., MS, MPH

Assistant Professor

The University of Oklahoma Health Sciences Center
Schusterman Center
4502 E. 41st Street, Room 1A14
Tulsa, Oklahoma 74135-2512

(405) 271-8001 ext. 12232

Elizabeth-Charron@ouhsc.edu

Elizabeth (Betsy) Charron, PhD, MS, MPH, is an Assistant Professor in the Department of Health Sciences, Hudson College of Public Health (OU-Tulsa campus). Dr. Charron is a community-engaged health services researcher working to improve access and quality of healthcare delivery for individuals with or at-risk of developing substance use disorders. Her primary interest is conducting mixed methods population-based and clinical research on topics related to women’s health and addiction. Dr. Charron’s projects have focused on expanding access to perinatal substance use treatment, examining quality of care in reproductive health service provision, and evaluating approaches to reduce the burden of substance use and related problems on pregnant/parenting persons and their children. Dr. Charron received her PhD from Clemson University, MPH from Tulane University, and completed postdoctoral training at the Program of Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, University of Utah School of Medicine. In her spare time, she enjoys hiking, gardening, and spending time with her family.

Education:

  • Postdoctoral Fellow, Program of Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, 2020-2021
  • PhD, Applied Health Research and Evaluation, Clemson University, 2020
  • MS, Applied Health Research and Evaluation, Clemson University, 2018
  • MPH, International Health and Development, Tulane University, 2011

Appointments:

  • Assistant Professor, Department of Health Promotion Sciences, Hudson College of Public Health, Oklahoma University Health Sciences Center, 2022-present
  • Adjunct Assistant Professor, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, 2022-present
  • Visiting Assistant Professor, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, 2022
  • Member, Early Career Members Committee, The College on Problems of Drug Dependence, 2021-Present

Clinical/Research Interests:

  • Substance use and addictions
  • Perinatal opioid use disorder and associated treatments
  • Improving health care delivery for vulnerable populations
  • Reproductive, maternal, and child health
  • Community-engaged health services research
  • Clinical and public health research and evaluation

Select Publications:

Link Link to Dr. Charron's current publications

Select publications:

  1. Charron E, Okifuji A, Bryan MA, Reese S, Brown JL, Ferguson A, Ghitza UE, Winhusen T, Cochran G. Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study. The Journal of Pain. 2022;23(8):1448-1459. doi:10.1016/j.jpain.2022.03.238
  2. Baylis JD, Charron E, Archer S, Garets M, Bryan MA, Foringer J, Kelley AT, Smid MC, Cochran G. Attitudes, self-efficacy, and practices related to opioid risk assessment and mitigation: A comparison of health care professionals in rural communities. Substance Abuse. 2022;43(1):1163-1171. doi:10.1080/08897077.2022.2074593
  3. Kelley AT, Smid MC, Baylis JD, Charron E, Begaye LJ, Binns-Calvey A, Archer S, Weiner S, Pettey W, Cochran G. Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. Journal of Substance Abuse Treatment. Published online December 2021:108685. doi:10.1016/j.jsat.2021.108685
  4. Charron E, Rennert L, Mayo RM, Eichelberger KY, Dickes L, Truong KD. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005–2016. Drug and Alcohol Dependence. 2021;220:108533. doi:10.1016/j.drugalcdep.2021.108533
  5. Charron E, Mayo RM, Heavner-Sullivan SF, Eichelberger KY, Dickes L, Truong KD, Rennert L. “It’s a very nuanced discussion with every woman”: Health care providers’ communication practices during contraceptive counseling for patients with substance use disorders. Contraception. 2020;102(5):349-355. doi:10.1016/j.contraception.2020.09.002